NSRGY - Nestlé To Develop Products For Users Of 'Miracle' Weight-Loss Drugs Like Ozempic Wegovy | Benzinga
Swiss food conglomerate, Nestlé SA (OTC:NSRGY), announced plans to create products that pair with popular weight-loss medications like Ozempic, Wegovy, and Mounjaro.
As per a Forbes report, this move comes amid concerns about the potential impacts these appetite-suppressing drugs might have on the food industry.
The company’s CEO, Mark Schneider, revealed during an earnings briefing that Nestlé is exploring health aids for the increasing number of individuals utilizing weight-loss treatments. These medications, originally designed to manage Type 2 diabetes, curtail the desire to eat by simulating an appetite-controlling gut hormone.
See Also: Novavax (NVAX) Stock Is Falling Today
Schneider noted that the reduced food intake presents an opportunity for Nestlé to introduce products such as supplements that can support weight loss while ensuring that individuals receive the necessary nutrients. These “companion products” could also ...